BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28167045)

  • 1. Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.
    Patel GC; Phan TN; Maddineni P; Kasetti RB; Millar JC; Clark AF; Zode GS
    Am J Pathol; 2017 Apr; 187(4):713-723. PubMed ID: 28167045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
    Patel GC; Millar JC; Clark AF
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice.
    Patel GC; Liu Y; Millar JC; Clark AF
    Sci Rep; 2018 Jan; 8(1):862. PubMed ID: 29339763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues.
    Clark AF; Steely HT; Dickerson JE; English-Wright S; Stropki K; McCartney MD; Jacobson N; Shepard AR; Clark JI; Matsushima H; Peskind ER; Leverenz JB; Wilkinson CW; Swiderski RE; Fingert JH; Sheffield VC; Stone EM
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1769-80. PubMed ID: 11431441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.
    Mao W; Tovar-Vidales T; Yorio T; Wordinger RJ; Clark AF
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8068-75. PubMed ID: 21911581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
    Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):437-46. PubMed ID: 19696178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
    Fingert JH; Clark AF; Craig JE; Alward WL; Snibson GR; McLaughlin M; Tuttle L; Mackey DA; Sheffield VC; Stone EM
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):145-52. PubMed ID: 11133859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach.
    Liang X; Li N; Rong Y; Wang J; Zhang H
    Exp Eye Res; 2022 Mar; 216():108914. PubMed ID: 34979099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells.
    Li G; Cui G; Dismuke WM; Navarro I; Perkumas K; Woodward DF; Stamer WD
    Exp Eye Res; 2017 Feb; 155():38-46. PubMed ID: 27939447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
    Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
    Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor-beta.
    Zhang X; Clark AF; Yorio T
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4607-16. PubMed ID: 16303956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of topical Ginkgo biloba extract on steroid-induced changes in the trabecular meshwork and intraocular pressure.
    Jia LY; Sun L; Fan DS; Lam DS; Pang CP; Yam GH
    Arch Ophthalmol; 2008 Dec; 126(12):1700-6. PubMed ID: 19064852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFATc1 activity regulates the expression of myocilin induced by dexamethasone.
    Faralli JA; Clark RW; Filla MS; Peters DM
    Exp Eye Res; 2015 Jan; 130():9-16. PubMed ID: 25450062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
    Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
    J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model.
    Sawaguchi K; Nakamura Y; Nakamura Y; Sakai H; Sawaguchi S
    Ophthalmic Res; 2005; 37(5):235-42. PubMed ID: 16020952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
    Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.
    McDowell CM; Luan T; Zhang Z; Putliwala T; Wordinger RJ; Millar JC; John SW; Pang IH; Clark AF
    Exp Eye Res; 2012 Jul; 100():65-72. PubMed ID: 22575566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X.
    Stamer WD; Hoffman EA; Kurali E; Krauss AH
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2100-7. PubMed ID: 23462748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma.
    Zode GS; Bugge KE; Mohan K; Grozdanic SD; Peters JC; Koehn DR; Anderson MG; Kardon RH; Stone EM; Sheffield VC
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1557-65. PubMed ID: 22328638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin.
    Kasetti RB; Maddineni P; Kiehlbauch C; Patil S; Searby CC; Levine B; Sheffield VC; Zode GS
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33539326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.